106 related articles for article (PubMed ID: 1980363)
1. Clinical use of dopamine receptor agonists.
Murphy MB
Proc West Pharmacol Soc; 1990; 33():31-5. PubMed ID: 1980363
[TBL] [Abstract][Full Text] [Related]
2. Dopamine and dopamine receptor agonists in cardiovascular therapy.
Murphy MB; Elliott WJ
Crit Care Med; 1990 Jan; 18(1 Pt 2):S14-8. PubMed ID: 1967161
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
Goldberg LI
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
[TBL] [Abstract][Full Text] [Related]
4. Role of dopamine receptors and the utility of dopamine agonists in heart failure.
Rajfer SI; Davis FR
Circulation; 1990 Aug; 82(2 Suppl):I97-102. PubMed ID: 1973645
[TBL] [Abstract][Full Text] [Related]
5. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
6. The role of dopamine receptors in the treatment of congestive heart failure.
Goldberg LI
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S19-27. PubMed ID: 2478806
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system].
Kostowski W
Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1448-51. PubMed ID: 2870482
[No Abstract] [Full Text] [Related]
8. Dopamine: receptors and clinical applications.
Goldberg LI
Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
[TBL] [Abstract][Full Text] [Related]
9. Dopamine: pharmacologic and therapeutic aspects.
Velasco M; Luchsinger A
Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of inodilators.
Dei Cas L; Metra M; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
[TBL] [Abstract][Full Text] [Related]
11. Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects.
Contreras F; Foullioux C; Pacheco B; Maroun C; Bolívar H; Lares M; Leal E; Cano R; Bermúdez V; Velasco M
Am J Ther; 2008; 15(4):397-402. PubMed ID: 18645345
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and dopamine receptors as target sites for cardiovascular drug action.
Berkowitz BA
Fed Proc; 1983 Oct; 42(13):3019-21. PubMed ID: 6137421
[TBL] [Abstract][Full Text] [Related]
13. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal action of dopaminergic prodrugs.
Casagrande C; Merlo L; Ferrini R; Miragoli G; Semeraro C
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S40-59. PubMed ID: 2483441
[TBL] [Abstract][Full Text] [Related]
15. Current literature questions the routine use of low-dose dopamine.
Abay MC; Reyes JD; Everts K; Wisser J
AANA J; 2007 Feb; 75(1):57-63. PubMed ID: 17304785
[TBL] [Abstract][Full Text] [Related]
16. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
17. Dopamine, depression and antidepressants.
Dailly E; Chenu F; Renard CE; Bourin M
Fundam Clin Pharmacol; 2004 Dec; 18(6):601-7. PubMed ID: 15548230
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview.
Missale C; Lombardi C; De Cotiis R; Memo M; Carruba MO; Spano PF
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S29-39. PubMed ID: 2483440
[TBL] [Abstract][Full Text] [Related]
19. Present and future trends in research and clinical applications of inodilators.
Cargnelli G; Piovan D; Bova S; Padrini R; Ferrari M
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S124-32. PubMed ID: 2483438
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapeutic profile of ibopamine in heart failure.
Taylor SH
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
